Ulcerative Colitis Stocks List

Ulcerative Colitis Stocks Recent News

Date Stock Title
May 31 ABBV Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
May 31 PTGX Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2024
May 31 ABBV AbbVie wins EU backing for Skyrizi in bowel disorder
May 31 ABBV AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
May 30 ROIV Roivant Sciences Ltd. (ROIV) Q4 2023 Earnings Call Transcript
May 30 ABBV AbbVie: Turnaround Lurking After The Correction Pain (Upgrade)
May 30 ABBV AbbVie: This Dividend Aristocrat Is Almost Buyable Again Now
May 30 ROIV Roivant Sciences GAAP EPS of -$0.19 beats by $0.11, revenue of $28.93M misses by $2.01M
May 30 ROIV Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update
May 30 ABBV 3 Dividend Stocks to Double Up on Right Now
May 30 LXRX Lexicon selects Medidata to advance Phase IIb non-opioid pain drug trial
May 29 ABBV Looking For Both Income And Growth? 4%-Yielding AbbVie Has You Covered
May 29 ABBV Are Options Traders Betting on a Big Move in AbbVie (ABBV) Stock?
May 29 ABBV AbbVie shares fell for seven straight days
May 29 ROIV Roivant Sciences Q4 2024 Earnings Preview
May 29 LXRX Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2024
May 28 ABBV AbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024 with New Data from Its Innovative Antibody-Drug Conjugate (ADC) Platform
May 28 LXRX Lexicon Pharmaceuticals: Blue Sky Aplenty, Revenue Not So Much
May 26 ABBV Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
Ulcerative Colitis

Ulcerative colitis (UC) is a long-term condition that results in inflammation and ulcers of the colon and rectum. The primary symptoms of active disease are abdominal pain and diarrhea mixed with blood. Weight loss, fever, and anemia may also occur. Often, symptoms come on slowly and can range from mild to severe. Symptoms typically occur intermittently with periods of no symptoms between flares. Complications may include megacolon, inflammation of the eye, joints, or liver, and colon cancer.The cause of UC is unknown. Theories involve immune system dysfunction, genetics, changes in the normal gut bacteria, and environmental factors. Rates tend to be higher in the developed world with some proposing this to be the result of less exposure to intestinal infections, or to a Western diet and lifestyle. The removal of the appendix at an early age may be protective. Diagnosis is typically by colonoscopy with tissue biopsies. It is a kind of inflammatory bowel disease (IBD) along with Crohn's disease and microscopic colitis.Dietary changes, such as maintaining a high-calorie diet or lactose-free diet, may improve symptoms. Several medications are used to treat symptoms and bring about and maintain remission, including aminosalicylates such as mesalazine or sulfasalazine, steroids, immunosuppressants such as azathioprine, and biologic therapy. Removal of the colon by surgery may be necessary if the disease is severe, does not respond to treatment, or if complications such as colon cancer develop. Removal of the colon and rectum can cure the disease.Together with Crohn's disease, about 11.2 million people were affected as of 2015. Each year it newly occurs in 1 to 20 per 100,000 people, and 5 to 500 per 100,000 individuals are affected. The disease is more common in North America and Europe than other regions. Often it begins in people aged 15 to 30 years, or among those over 60. Males and females appear to be affected in equal proportions. It has also become more common since the 1950s. Together, ulcerative colitis and Crohn's disease affect about a million people in the United States. With appropriate treatment the risk of death appears the same as that of the general population. The first description of ulcerative colitis occurred around the 1850s.

Browse All Tags